1Cell.Ai Marks Major Milestone with Successful CLIA Validation of OncoIncytes 1080-Gene NGS Panel 1Cell.Ai has concluded a successful CLIA validation study for its OncoIncytes 1080-gene NGS panel, enhancing cancer diagnostics with advanced profiling.

1Cell.Ai Marks Major Milestone with Successful CLIA Validation of OncoIncytes 1080-Gene NGS Panel #United_States #Foster_City #OncoIncytes #1Cell.Ai #NGS_panel